Oxbryta (Voxelotor) Clinical Study Analysis Strives to Get Sickle Cell Disease Treatment Back on Market by Madaline Spencer| Published on: May 21, 2026

Oxbryta (Voxelotor) Clinical Study Analysis Strives to Get Sickle Cell Disease Treatment Back on Market by Madaline Spencer| Published on: May 21, 2026 A recent clinical study analysis of Oxbryta (voxelotor), globally withdrawn in 2024, was submitted to the FDA with the intent of getting voxelotor back on the market. https://checkrare.com/oxbryta-voxelotor-clinical-study-analysis-strives-to-get-sickle-cell-disease-treatment-back-on-market/